Wef-001

Advanced or Metastatic KRAS-mutant Tumor in Non Small Cell Lung Cancer

Auricula Biosciences Inc.Phase 1/2

—

Rating in progress

Wef-001 in Advanced or Metastatic KRAS-mutant Tumor in Non Small Cell Lung Cancer is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.

Methodology v0.2 · Active